The Conseil d’État’s study “Artificial Intelligence and Public Action” of August 2022, raised several questions around the use of artificial intelligence (AI) and megadata by public authorities. These issues are particularly important in the healthcare sector, where the most recent technological developments suggest new ways of using data and artificial intelligence, for the benefit of patients.
To address these issues, the Conseil d’État, the CNIL and Alliance IHU France are organizing a day of work and discussion on February 10, 2023, from 9 a.m. to 3:45 p.m., bringing together doctors, researchers, regulators, industrialists and entrepreneurs, and political decision-makers: AI and megadata, how will they revolutionize tomorrow’s research and medical practice?
The IHU model presented at the 13th edition of the Autumn School on Creativity Management
From November 7 to 11 at key locations in Strasbourg and surroundings
Organized by the BETA (Bureau d’Économie Théorique et Appliquée) of the University of Strasbourg and MosaiC, Pôle créativité & innovation – HEC Montréal, the Autumn School in Creativity Management offers a rich and diversified week-long program.
Promoting the acquisition of new knowledge through new practices around creativity in our organizations and our territories, this week-long training event draws on the real-life skills of its participants: entrepreneurs, executives, decision-makers, managers, creators from various fields of activity, general management, marketing, innovation and R&D managers, young entrepreneurs and associates.
Jean-Luc Dimarcq, Director of Development of the IHU, will speak on the subject of the IHU’s ‘original models to boost innovation in health’ on Wednesday, November 9 at 2pm at the European Doctoral College, 46 Boulevard de la Victoire, Strasbourg.
MICCAI AE-CAI 2022 – Outstanding paper award to IHU authors
Congratulations to IHU’s APEUS team. The authors of the paper* entitled ‘Automatic pancreas anatomical part detection in endoscopic ultrasound videos’ won the OUTSTANDING PAPER AWARD, which was collected by Adrien Meyer, AI Research engineer at IHU, at the MICCAI AE-CAI 2022 workshop held in Singapore on 18 September.
The joint 16th AE-CAI, 9th CARE and 5th OR 2.0 workshop brought together researchers, clinicians, and medical companies that are working on advancing the field of Medical Imaging and Augmented Reality, Augmented Environments for Computer Assisted Interventions (AE-CAI), Computer Assisted and Robotic Endoscopy (CARE) and Context-Aware Operating Theaters (OR 2.0).
*The paper was co-authored by Antoine Fleurentin, Jean-Paul Mazellier, Adrien Meyer, Julieta Montanelli, Lee Swanstrom, Benoit Gallix, Leonardo Sosa Valencia, and Nicolas Padoy. It was presented at the workshop by Adrien Meyer.
Second edition of CLINICCAI during MICCAI 2022 conference
The second edition of CLINICCAI (Clinical translation of Medical Image Computing and Computer Assisted Intervention) was held in Singapore, after a successful first edition organized during MICCAI-2021 in Strasbourg. CLINICCAI-2022 took place at the Resorts World Convention Centre as part of the core program of the MICCAI 2022 conference, with an active participation of the IHU Strasbourg’s team as part of the Organizing Committee. The event was conceived to provide a platform for healthcare practitioners working on translational research in the areas of MICCAI to present their work and to enable and promote networking among biomedical scientists and clinicians.
A total of 20 oral presentations were selected among 31 submissions (from 13 countries) according to their relevance, novelty, and their potential for clinical translation. More than 60 healthcare professionals registered and traveled from 14 countries to present and participate on-site, with over 550 total attendees throughout the conference.
An international jury presided by Prof. Jason Chan (Chinese University of Hong Kong), and including experts from UK (Heike Grabsch), Switzerland (Inti Zlobec), and France (Juan Verde), selected the best three presentations and delivered the IHU best presentation award to: Jorge Corral Acero, Pieter De Baker, and Fiona Kolbinger. Congratulations to them!
We are anxiously awaiting the confirmation of the third edition of CLINICCAI, expected to take place next year in October, in Vancouver, Canada, during the 26th International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI-2023) with the support of the IHU Strasbourg and its team!
As part of the Government’s 5G Mission entrusted to Philippe Herbet, the Electronic Communications, Postal and Print media distribution Regulatory Authority (Arcep) authorized on October 12 the experimentation in the 3.8 – 4.0 GHz band at the IHU Strasbourg in order to promote access to 5G for industrialists and “vertical” players (local authorities, universities, research laboratories, etc.).
The IHU has been granted one of the 13 experimental authorizations issued by Arcep, covering various sectors of the economy: industry, energy and health.
The thirteen experimental authorizations in the 3.8 – 4.0 GHz band as of October 12, 2022 (Source: Arcep)
Strasbourg University-Hospital Institute (IHU)
A part of the Franco-German “5G-OR” project, the experiment aims to create the first demo of a new generation of operating room communicating within a private 5G network, for personalized and secure minimally invasive interventions, with the objective of improving patient benefit. The French team involves two institutes created by the Investissements d’Avenir program – the Strasbourg University Hospital Institute and the b<>com Technological Research Institute, as well as the innovative company RDS Diagnostics.
On 4 May 2022, a hybrid kick-off meeting took place for the eCAP project: recipient of a €4.7 million grant from the European Union’s Research and Innovation Programme Horizon Europe. The aim of the project is to deliver a novel medical device combining a smart capsule with an e-health platform to enable better diagnostics, patient empowered disease management and hence, improved outcomes for patients with gastrointestinal (GI) diseases, a major source of population morbidity and care costs worldwide. The consortium, composed of 10 partners from research organisations and industry across Europe and Kenya, will demonstrate the universality of the eCAP solution in clinical trials in France as well as low resource environments by bringing the device to patients who so far have had limited access to GI disease diagnostics.
GI diseases, which range from functional problems to cancers, are among the most common medical ailments across the globe. Gastroesophageal reflux disease (GERD) alone affects an estimated 1.2 billion people globally, with prevalence growing in all regions of the world. Many GI diseases are difficult to diagnose as the symptoms are often vague and variable. Moreover, currently available diagnostics requires highly skilled interpretation and high set-up cost, leading to a dramatic lack of access. For instance, GERD is subject to definitive diagnostic testing in less than 2% of cases.
eCAP enabled diagnostics of GI disease
The eCAP consortium will develop a smart multi-sensing capsule, implanted by minimally invasive techniques, that enables GI physiology monitoring for a controlled period of time. Using ubiquitous smartphone communication standards and cloud computing, real-time patient experience data will be collected through an interactive user-friendly application. Patient-empowered disease management will be supported by accurate interpretation of the data by physicians, aided by Artificial Intelligence. “More accurate, cost-effective, patient-friendly testing for acid reflux is an increasingly urgent need today that the current solutions out on the market do not meet.I think the exciting thing is that this particular group of partners is uniquely suited to getting together to solve the problem of GI diseases affecting people worldwide”, explains Lee Swanström, Project Coordinator from the IHU Strasbourg. “As we began discussions, we had great ideas for expanding the initial proof of concept, even beyond GERD testing, so the project has enormous potential. We certainly thank the European community for recognizing our vision and supporting this project.”
eCAP will run for four years and draw on world-class expertise. The project is led by the Institute of Image-Guided Surgery of Strasbourg (FR). Technical solutions will be developed by Tyndall National Institute (IE), Sentron Europe BV (NL), Integer (IE) and Enterasense (IE), based on the user design input from Imagination Factory (UK). Clinical studies in Kenya and Ukraine will be conducted by Operating Theatre Practitioners Association of Kenya (OTPAK, KE) and a gastroenterology and endoscopy clinic in Kyiv – Olymed (UA), which continues to be actively involved in the project, despite the devastating hurdles they are undergoing today. Health economic analysis will be undertaken by Betthera (CZ) and project management and dissemination activities by AMIRES, The Business Innovation Management Institute (CZ).
We use cookies on our website to provide you with the most relevant experience by remembering your preferences and repeat visits. By clicking on "Accept all", you consent to the use of ALL cookies. However, you can consult the "Cookie settings" section to give a personalized and controlled consent.
This website uses cookies to enhance your experience when browsing the site. Among these cookies, those that are considered necessary are stored on your browser, as they are essential to the operation of the website's basic functions. We also use third-party cookies to help us analyze and understand how you use this website. These cookies will only be stored in your browser with your consent. You also have the option of refusing these cookies. However, disabling some of these cookies may affect your browsing experience.
Functional cookies enable certain functionalities such as sharing website content on social media platforms, collecting comments and other third party functions.
Analytical cookies are used to understand how visitors interact with the website. These cookies provide information about the number of visitors, bounce rate, traffic source, etc.
Advertising cookies are used to provide visitors with relevant advertisements and marketing campaigns. These cookies track visitors across websites and collect information to provide personalized advertisements.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionality and security features of the website, in an anonymous manner.
Recent Comments